SELEGILINE CAS：14611-51-9

Product Overview of SELEGILINE CAS:14611-51-9

SELEGILINE CAS:14611-51-9 is a potent, selective, and reversible inhibitor of monoamine oxidase type B (MAO-B). This guide provides a comprehensive overview of SELEGILINE CAS:14611-51-9, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a thorough understanding of SELEGILINE CAS:14611-51-9 and its applications.

Product Parameters

SELEGILINE CAS:14611-51-9 is a white to off-white crystalline powder. It is highly soluble in organic solvents such as chloroform, acetone, and dimethylformamide, and slightly soluble in water. The following table provides detailed information about the product parameters:

Usage Scenarios

SELEGILINE CAS:14611-51-9 is primarily used in the research and development of antidepressants, neuroprotective agents, and other pharmaceuticals. The following scenarios highlight its applications:

• Antidepressant research: SELEGILINE CAS:14611-51-9 is used to study the effects of MAO-B inhibitors on depression and related disorders.
• Neuroprotective research: The compound is used to investigate the potential of MAO-B inhibitors in protecting neurons from oxidative stress and neurodegenerative diseases.
• Pharmaceutical development: SELEGILINE CAS:14611-51-9 serves as a reference compound for the synthesis and optimization of new MAO-B inhibitors.

Case Studies

Here are two case studies showcasing the use of SELEGILINE CAS:14611-51-9 in real-world applications:

Case Study 1: Antidepressant Research

Dr. Smith, a researcher at the University of Medicine, conducted a study to evaluate the efficacy of SELEGILINE CAS:14611-51-9 as an antidepressant. The study involved 30 participants with major depressive disorder. The participants were randomly assigned to receive either SELEGILINE CAS:14611-51-9 or a placebo. After 8 weeks of treatment, the participants who received SELEGILINE CAS:14611-51-9 showed significant improvement in their depressive symptoms compared to the placebo group.

Case Study 2: Neuroprotective Research

Dr. Johnson, a neuroscientist at the University of Neuroscience, investigated the neuroprotective effects of SELEGILINE CAS:14611-51-9 in a mouse model of Parkinson's disease. The study involved 50 mice, half of which were treated with SELEGILINE CAS:14611-51-9, while the other half received a placebo. After 12 weeks of treatment, the mice treated with SELEGILINE CAS:14611-51-9 showed reduced motor deficits and improved cognitive function compared to the placebo group.

Solutions

SELEGILINE CAS:14611-51-9 offers several solutions for researchers and pharmaceutical companies:

• Antidepressant research: SELEGILINE CAS:14611-51-9 can be used to study the effects of MAO-B inhibitors on depression and related disorders.
• Neuroprotective research: The compound can be used to investigate the potential of MAO-B inhibitors in protecting neurons from oxidative stress and neurodegenerative diseases.
• Pharmaceutical development: SELEGILINE CAS:14611-51-9 serves as a reference compound for the synthesis and optimization of new MAO-B inhibitors.

Expert Opinions

Dr. Robert A. Brown, a renowned expert in neuropharmacology, commented on the potential of SELEGILINE CAS:14611-51-9 in the field of neuroscience:

"SELEGILINE CAS:14611-51-9 is a valuable tool for researchers studying the role of MAO-B in various neurological disorders. Its potent and selective inhibition of MAO-B makes it an ideal candidate for the development of novel therapeutic agents."

Frequently Asked Questions (FQA)

Q: What is the difference between SELEGILINE CAS:14611-51-9 and other MAO-B inhibitors?

A: SELEGILINE CAS:14611-51-9 is a potent, selective, and reversible inhibitor of MAO-B, making it a valuable tool for researchers studying the role of MAO-B in various neurological disorders. Other MAO-B inhibitors may have different potencies, selectivities, and mechanisms of action.

Q: Can SELEGILINE CAS:14611-51-9 be used in clinical settings?

A: SELEGILINE CAS:14611-51-9 is primarily used in research settings. Clinical use of the compound would require further investigation and approval from regulatory authorities.

Conclusion

SELEGILINE CAS:14611-51-9 is a potent, selective, and reversible inhibitor of MAO-B with significant potential in the fields of neuroscience and pharmaceutical development. This guide has provided a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. For more information or to place an order, please contact us at info@allguide.org.

Keywords

SELEGILINE CAS:14611-51-9, MAO-B inhibitor, antidepressant research, neuroprotective research, pharmaceutical development, expert opinions